» Authors » Yusuke S Hori

Yusuke S Hori

Explore the profile of Yusuke S Hori including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 391
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Harary P, Rajaram S, Hori Y, Park D, Chang S
J Neurooncol . 2025 Mar; PMID: 40063185
Purpose: Craniopharyngiomas (CPs) are rare, slow-growing brain tumors which originate in the sellar region. CPs may present with symptoms secondary to compression of surrounding structures, particularly the pituitary gland, and...
2.
Lam F, Guru S, AbuReesh D, Hori Y, Chuang C, Liu L, et al.
Brain Sci . 2025 Feb; 15(2). PMID: 40002531
Current standard of care treatment for patients with spine tumors includes multidisciplinary approaches, including the following: (1) surgical tumor debulking, epidural spinal cord decompression, and spine stabilization techniques; (2) systemic...
3.
Akhavan-Sigari A, Park D, Harary P, Chivakula M, Theodros D, Bharani K, et al.
J Neurosurg Case Lessons . 2025 Jan; 9(3. PMID: 39832313
Background: The co-occurrence of Rathke cleft cysts (RCCs) and meningiomas in the sellar and parasellar regions represents an exceedingly rare clinical entity. Achieving maximal resection through a single operative approach...
4.
Guru S, Lam F, Akhavan-Sigari A, Hori Y, AbuReesh D, Tayag A, et al.
Brain Sci . 2025 Jan; 14(12. PMID: 39766452
The current standard of care for brain tumor management includes maximal safe surgical resection followed by concurrent chemotherapy and radiation therapy. Recent advances in image-guided surgical techniques have enhanced the...
5.
Harary P, Rajaram S, Chen M, Hori Y, Park D, Chang S
Cell Death Discov . 2024 Dec; 10(1):501. PMID: 39695143
Radiotherapy remains a key treatment modality for both primary and metastatic brain tumors. Significant technological advances in precision radiotherapy, such as stereotactic radiosurgery and intensity-modulated radiotherapy, have contributed to improved...
6.
Harary P, Hori Y, Annagiri S, Akhavan-Sigari A, Persad A, Ustrzynski L, et al.
J Clin Neurosci . 2024 Nov; 130():110927. PMID: 39571478
Background: Neuroendocrine tumor (NET) brain metastases (BM) are rare malignancies which frequently bear a poor prognosis and have the potential to secrete hormones. The optimal treatment approach for these metastases...
7.
Akhavan-Sigari A, Hori Y, Harary P, Persad A, Kassu R, Tayag A, et al.
World Neurosurg . 2024 Nov; 194:123387. PMID: 39491621
Background: Choriocarcinoma (CC) is a rare and aggressive form of germ cell tumor. There is limited evidence describing clinical outcomes in patients with primary CC and brain metastases (BM). Only...
8.
Harary P, Hori Y, Persad A, Tayag A, Ustrzynski L, Emrich S, et al.
J Neurosurg Case Lessons . 2024 Sep; 8(11). PMID: 39250830
Background: While genetic testing of tumors is commonly used to inform the selection of systemic therapies, there is limited evidence for the application of radiotherapy for brain cancer. Recent studies...
9.
Hori Y, Park D, Chang S
World Neurosurg . 2024 Aug; 191:186-189. PMID: 39168242
Bilateral orbital metastases are extremely rare, and no previous literature has reported bilateral multiple orbital metastases treated with stereotactic radiosurgery (SRS). We present the impressive images of a patient with...
10.
Chou K, Park D, Hori Y, Persad A, Chuang C, Emrich S, et al.
J Neurosurg Spine . 2024 Aug; 41(4):532-540. PMID: 39126716
Objective: This study aimed to retrospectively evaluate the efficacy of stereotactic body radiotherapy (SBRT) for pain relief in patients with painful spinal bone metastases (SBMs) and to identify key factors...